Marker Therapeutics Stock Technical Analysis
| MRKR Stock | USD 3.10 0.15 5.08% |
As of the 23rd of November, Marker Therapeutics secures the Risk Adjusted Performance of 0.0087, mean deviation of 5.13, and Standard Deviation of 7.16. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Marker Therapeutics, as well as the relationship between them. Please verify Marker Therapeutics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Marker Therapeutics is priced some-what accurately, providing market reflects its recent price of 3.1 per share. Given that Marker Therapeutics has information ratio of (0.02), we recommend you to check Marker Therapeutics's last-minute market performance to make sure the company can sustain itself at a future point.
Marker Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Marker, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MarkerMarker |
Marker Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 40.0 | Strong Buy | 1 | Odds |
Most Marker analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Marker stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Marker Therapeutics, talking to its executives and customers, or listening to Marker conference calls.
Marker Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Marker Therapeutics Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Marker Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Marker Therapeutics Trend Analysis
Use this graph to draw trend lines for Marker Therapeutics. You can use it to identify possible trend reversals for Marker Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Marker Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Marker Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Marker Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.02 , which means Marker Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 9.67, which is the sum of squared deviations for the predicted Marker Therapeutics price change compared to its average price change.About Marker Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Marker Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Marker Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Marker Therapeutics price pattern first instead of the macroeconomic environment surrounding Marker Therapeutics. By analyzing Marker Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Marker Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Marker Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 26.61 | 13.75 | 7.56 | 7.19 | Receivables Turnover | 5.2K | 3.75 | 3.37 | 3.21 |
Marker Therapeutics November 23, 2024 Technical Indicators
Most technical analysis of Marker help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Marker from various momentum indicators to cycle indicators. When you analyze Marker charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0087 | |||
| Market Risk Adjusted Performance | 0.0048 | |||
| Mean Deviation | 5.13 | |||
| Coefficient Of Variation | (326,593) | |||
| Standard Deviation | 7.16 | |||
| Variance | 51.3 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | (0.01) | |||
| Maximum Drawdown | 37.38 | |||
| Value At Risk | (11.56) | |||
| Potential Upside | 8.87 | |||
| Skewness | 0.8913 | |||
| Kurtosis | 2.62 |
Additional Tools for Marker Stock Analysis
When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.